Osiris Promotes Debrabandere to Top Spot as CEO Mills Steps Down

Osiris Therapeutics Inc., the maker of the Grafix wound treatment, said Chief Executive Officer C. Randal Mills is stepping down and will be replaced by current chief operating officer, Lode Debrabandere.

http://washpost.bloomberg.com/Story?docId=1376-MX79HM6TTDSF01-3Q369ILOUSCQC2T1SKP39L9S5C